Manuel I. Hermosilla
Skip to content
Take the Kellogg Insight Reader Survey

Manuel I. Hermosilla

Pharma Companies Argue That Lower Drug Prices Would Mean Fewer Breakthrough Drugs. Is That True?

Probably not, a new study suggests—as long as the price decreases are modest.

Researchers: David Dranove, Craig Garthwaite and Manuel I. Hermosilla

September 2, 2020

Healthcare